Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | DRD2 | P14416 | 3/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.33 |
| ▸ | BCHE | P06276 | 5/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.32 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.32 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.32 |
| ▸ | DRD1 | P21728 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27874029 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL28254296 | 0.72 | — | — | |
| SCHEMBL27787700 | 0.68 | TRPA1 (0.34) | TRPA1DRD2BACE1 | |
| SCHEMBL272379 | 0.67 | IDO1 (0.31) | — | |
| SCHEMBL29473567 | 0.67 | IDO1 (0.31) | — | |
| SCHEMBL21834864 | 0.67 | DRD2 (0.33) | TRPA1DRD2RAB9AMAPTBACE1 | |
| SCHEMBL4760147 | 0.67 | TRPA1 (0.36) | TRPA1DRD2BACE1 | |
| SCHEMBL2594107 | 0.66 | TRPA1 (0.33) | TRPA1BACE1CYP19A1 | |
| SCHEMBL27458463 | 0.66 | IDO1 (0.30) | — | |
| SCHEMBL27954167 | 0.65 | TRPA1 (0.38) | TRPA1BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120025350-A | Organic compound, preparation method thereof, composition, photoelectric device and display device | TCL科技集团股份有限公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-114133408-B | Boron-based compound and application thereof in organic electroluminescent device | 武汉尚赛光电科技有限公司 | 2024-05-14 | — | — | CN | disclosed |
| US-11377415-B2 | Method for converting N,N-dialkylamide compound into ester compound using complex of fourth-period transition metal as catalyst | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2022-07-05 | — | — | US | disclosed |
| EP-3760607-A1 | METHOD FOR CONVERTING N,N-DIALKYLAMIDE COMPOUND INTO ESTER COMPOUND USING COMPLEX OF FOURTH-PERIOD TRANSITION METAL AS CATALYST | Takasago International Corporation (JP) | 2021-01-06 | — | — | EP | disclosed |
| US-20200399200-A1 | METHOD FOR CONVERTING N,N-DIALKYLAMIDE COMPOUND INTO ESTER COMPOUND USING COMPLEX OF FOURTH-PERIOD TRANSITION METAL AS CATALYST | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2020-12-24 | — | — | US | disclosed |
| US-9169206-B2 | Organic semiconductor compound, method for preparing the same, and organic semiconductor composition, and organic semiconductor thin film and element containing the same | LUMINANO CO., LTD. (KR) | 2015-10-27 | — | — | US | disclosed |
| CN-102675352-A | Lithium pyridine formate complex, preparation method thereof and organic electroluminescent device | BOE TECHNOLOGY GROUP CO LTD | 2012-09-19 | — | — | CN | disclosed |
| CN-101874316-B | Organic EL element and solution containing organic EL material | IDEMITSU KOSAN CO | 2012-09-05 | — | — | CN | disclosed |
| CN-101730948-B | organic electroluminescent element | IDEMITSU KOSAN CO | 2012-08-22 | — | — | CN | disclosed |
| CN-102558163-A | Functionalized anthracene end-capped oligothiophene, organic semiconductor based on oligothiophene and application thereof | CHINESE ACAD INST CHEMISTRY | 2012-07-11 | — | — | CN | disclosed |
| CN-102443144-A | Branched polythiophene derivatives, method for producing same and use thereof | CHINESE ACAD INST CHEMISTRY | 2012-05-09 | — | — | CN | disclosed |
| CN-102442993-A | Compound having dibenzo group and its derivative, process for producing them and use thereof | CHINESE ACAD INST CHEMISTRY | 2012-05-09 | — | — | CN | disclosed |
| CN-101849953-B | Inflammatory cytokine release inhibitor | INST MED MOLECULAR DESIGN INC | 2012-04-25 | — | — | CN | disclosed |
| CN-102369615-A | Organic electroluminescent element and material for organic electroluminescent element | IDEMITSU KOSAN CO | 2012-03-07 | — | — | CN | disclosed |
| CN-102334210-A | Organic electroluminescent element | IDEMITSU KOSAN CO | 2012-01-25 | — | — | CN | disclosed |
| US-20110253944-A1 | NOVEL ORGANIC SEMICONDUCTOR COMPOUND, METHOD FOR PREPARING SAME, AND ORGANIC SEMICONDUCTOR COMPOSITION, AND ORGANIC SEMICONDUCTOR THIN FILM AND ELEMENT CONTAINING THE SAME | LUMINANO CO., LTD. (KR) | 2011-10-20 | — | — | US | disclosed |
| CN-1202800-A | Herbicidal composition | NOVARTIS AG (CH) | 1998-12-23 | — | — | CN | disclosed |
| CN-1144526-A | Thiazolidines and oxazolidines substituted by pyridine ring and their use a hypoglycemic agents | NISSAN CHEMICAL IND LTD (JP) | 1997-03-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11377415-B2 | Method for converting N,N-dialkylamide compound into ester compound using complex of fourth-period transition metal as catalyst | NEK4, TENT4A, TCF4 | TRPA1 2148/4885DRD2 2975/4885RAB9A 2221/4885 |
| US-20110253944-A1 | NOVEL ORGANIC SEMICONDUCTOR COMPOUND, METHOD FOR PREPARING SAME, AND ORGANIC SEMICONDUCTOR COMPOSITION, AND ORGANIC SEMICONDUCTOR THIN FILM AND ELEMENT CONTAINING THE SAME | TYR, FTO, PIEZO1 | TRPA1 40/4885DRD2 1830/4885RAB9A 1951/4885 |
| US-20200399200-A1 | METHOD FOR CONVERTING N,N-DIALKYLAMIDE COMPOUND INTO ESTER COMPOUND USING COMPLEX OF FOURTH-PERIOD TRANSITION METAL AS CATALYST | NEK4, TENT4A, TCF4 | TRPA1 2148/4885DRD2 2975/4885RAB9A 2221/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.